Desq Long
Sign in

Company

Camp4 Therapeutics Corp

CAMP · CIK 0001736730

SEC FORM 4
$39,600.00

Camp4 Therapeutics Corp (CAMP)

Purchase of 10,000 shares at $3.96 per share.

Reporting Person Gold Kelly · Officer Title Chief Financial Officer · Transaction Code P

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001628280-26-060234 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,616,000.00

Camp4 Therapeutics Corp (CAMP)

Sale of 400,000 shares at $4.04 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001598549-26-000011 · filed 2026-08-31 · View filing →

SEC FORM 4
$45.00

Camp4 Therapeutics Corp (CAMP)

Sale of 10 shares at $4.50 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001598549-26-000009 · filed 2026-08-26 · View filing →

SEC FORM 4
$144,081.00

Camp4 Therapeutics Corp (CAMP)

Sale of 32,018 shares at $4.50 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001598549-26-000007 · filed 2026-08-21 · View filing →

SEC FORM 4
$520,738.00

Camp4 Therapeutics Corp (CAMP)

Sale of 114,700 shares at $4.54 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001598549-26-000007 · filed 2026-08-21 · View filing →

SEC FORM 4
$214,899.72

Camp4 Therapeutics Corp (CAMP)

Sale of 45,147 shares at $4.76 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001598549-26-000007 · filed 2026-08-21 · View filing →

SEC FORM 4
$8,272.88

Camp4 Therapeutics Corp (CAMP)

Sale of 1,738 shares at $4.76 per share.

Reporting Person Tardiff Daniel · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001628280-26-058107 · filed 2026-08-19 · View filing →